Intervention Review

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

  1. Lorna Gibson2,
  2. David Lawrence3,
  3. Claire Dawson1,
  4. Judith Bliss1,*

Editorial Group: Cochrane Breast Cancer Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 29 JUN 2008

DOI: 10.1002/14651858.CD003370.pub3

How to Cite

Gibson L, Lawrence D, Dawson C, Bliss J. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD003370. DOI: 10.1002/14651858.CD003370.pub3.

Author Information

  1. 1

    The Institute of Cancer Research, Clinical Trials and Statistics Unit, Sutton, Surrey, UK

  2. 2

    London School of Hygiene and Tropical Medicine, Cancer and Public Health Unit, London, Greater London, UK

  3. 3

    Cancer Research UK and UCL Cancer Trials Centre, London, UK

*Judith Bliss, Clinical Trials and Statistics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK. j.bliss@icr.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

  1. Current Version

    Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD003370.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Lorna Gibson, Claire Dawson, David Lawrence and Judith Bliss

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD003370.pub2

  2. Version 1

    Aromatase Inhibitors for treatment of metastatic breast cancer

    J Bliss and L Gibson

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD003370